Eli Lilly (NYSE:LLY) is in advanced discussions to purchase cancer-focused biotech Scorpion Therapeutics for as much as $2.5 billion.
https://seekingalpha.com/news/4394211-eli-lilly-in-talks-to-acquire-scorpion-therapeutics-ft-says-relay-therapeutics-surges
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.